| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802942201013 | 294220101 | ZAOLIN SOL.INF 10MG/ML BTx1 VIAL x 1 ML | 05.09 | 5.34 | 7.36 |
| 05/2018 | 2802942202010 | 294220201 | ZAOLIN SOL.INF 50MG/5ML BTx1 VIAL x 5 ML | 23.13 | 24.26 | 33.43 |
For the treatment of non-small-cell lung carcinoma.
The antitumor activity of vinorelbine is thought to be due primarily to inhibition of mitosis at metaphase through its interaction with tubulin. Vinorelbine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Like other vinca alkaloids, vinorelbine may also interfere with: 1) amino acid, cyclic AMP, and glutathione metabolism, 2) calmodulin-dependent Ca<sup>2+</sup>-transport ATPase activity, 3) cellular respiration, and 4) nucleic acid and lipid biosynthesis.
27.7-43.6 hours
Vinorelbine undergoes substantial hepatic elimination in humans, with large amounts recovered in feces after intravenous administration to humans.
* 25.4 to 40.1 L/kg
* 0.97 - 1.26 L/hr/kg